On October 20, 2023, HOOKIPA Pharma Inc. announced that Christine Baker, the company?s Chief Operating Officer, resigned on October 16, 2023 and will be leaving the Company on January 15, 2024, following a garden leave period commencing on November 1, 2023. The Company does not intend to fill the Chief Operating Officer role, and Ms. Baker?s responsibilities will be overseen by other members of the company?s management team.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.962 USD | +7.69% | +36.55% | +19.19% |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call | |
Apr. 25 | HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.19% | 88.39M | |
+25.48% | 661B | |
+26.74% | 566B | |
-6.55% | 352B | |
+20.37% | 332B | |
+2.92% | 283B | |
+13.42% | 231B | |
+4.70% | 200B | |
-9.41% | 195B | |
-5.19% | 145B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Inc. Announces Resignation of Christine Baker as Chief Operating Officer, Leaving on January 15, 2024